Long Beach, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced today that Brian Murphy, MD, Chief Executive Officer of Emerald Bioscience will present at several upcoming investment… Read More..
Long Beach, CA, Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, announced today the appointments of Dennis D. Kim, MD, MBA, as Chief Medical Officer, and Alice Chen as Executive Director, Clinical Operations. “We are pleased… Read More..
Presentation on Thursday, September 5, 2019 at 9:00am EST NEW YORK, NY, Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Qrons Inc. (QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of traumatic brain injuries, including concussions and penetrating injuries, announced today that it… Read More..